Navigation Links
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
Date:4/25/2009

perty protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, while the Company has begun shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to acceptance of future shipments and FDA's approval of the Company's Biologics License Application for ABthrax, if and when it is submitted. If the Company is unable to meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of new information, future events or circumstances or otherwise.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
2. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. First Human Study to Show Sun Chlorella A Supports Heart Health
5. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
6. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
7. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
8. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
9. Drug Development Program Started Based on CAP(R) Human Cell Line
10. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
11. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today ... the Goldman Sachs 36th Annual Global Healthcare Conference in ... Wednesday, June 10, 2015 at 4:00pm PT.   ... available on the Investor Relations page of the Company,s ... the presentation will begin approximately one hour after the ...
(Date:6/2/2015)... , Minn. and WELLESLEY, Mass., June 2, 2015 ... owner, Ampersand Capital Partners (Ampersand), announced the acquisition ... of Array BioPharma Inc. (Array).  Accuratus was formed ... Eagan, MN acquired Microtest Labs ... analytical and microbial testing services to the medical ...
(Date:6/2/2015)...  Nektar Therapeutics (NASDAQ: NKTR ) and The ... a research collaboration that includes a Phase 1/2 clinical ... preferentially stimulate production of CD8-positive T cells, which are ... which is also known as the Interleukin-2 receptor beta ... to increase proliferation of these effector T cells. 1 ...
Breaking Medicine Technology:Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 4Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 5Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 6
... Pharmasset, Inc. (Nasdaq: VRUS ) announces that ... to be held September 20-22, 2010 at the Grand Hyatt, ... Officer, will provide an overview of the company at the ... (ET). To access a simultaneous webcast of Mr. ...
... (NYSE: ALR ) announced today that, in connection ... due 2018, it entered into a purchase agreement with the ... size of the offering was increased from $350.0 million to ... are being offered at 100.0% of the aggregate principal amount ...
Cached Medicine Technology:Pharmasset to Present at the UBS Global Life Sciences Conference 2Pharmasset to Present at the UBS Global Life Sciences Conference 3Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million 2
(Date:6/2/2015)... (PRWEB) June 02, 2015 Milton Hershey ... one of the 30 members of the Physician Assistant ... of Medicine. He was presented with a white coat, ... , “We are extremely proud of Vincent’s accomplishments both ... “He is a great example of how a top-notch ...
(Date:6/2/2015)... 2015 Erbelli’s Gourmet Pizzeria, Italian Bistro ... its handmade gourmet pizzas and calzones, fresh wraps, submarine ... is new, the recipes are not—they have been satisfying ... feature of the site is the menu, which is ... of all the items. You can order directly from ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 IMPAK ... sorbent systems, has announced the availability of “child-resistant” ... of poisons by children, especially curious toddlers. The ... standards and tested to CFR 1700.20 protocols. The ... Cullen. , Looks Like Candy, “With the proliferation ...
(Date:6/2/2015)... Acara Partners has seen a spike in ... mobile devices, as is now required by recent Google search ... well as several new clients in the medical aesthetics vertical, ... them to meet Google’s new requirements,” commented Fran Acunzo, CEO ... clients in education, non-profits, and the business world.” , ...
(Date:6/2/2015)... DiaTech Oncology, provider of CorrectChemo®, ... to help oncologists provide personalized cancer treatment, has ... (CAP) for its laboratories in the U.S. and ... to the ‘Good Housekeeping’ seal of approval,” says ... for DiaTech. “It’s a rigorous inspection that confirms ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Acara Partners Expands Website and Digital Offerings 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2
... Organization Los Angeles, (EO-LA) May Chapter event tonight, CVS ... along the way from CVS,s inception to the retail ... the Andaz West Hollywood Hotel, located at 8401 Sunset ... Mr. Hoagland will take place in the rooftop Panorama ...
... 12 The "Benzene Litigation Conference" will take ... panel of highly experienced attorneys and health experts. ... Metzger Law Group in Long Beach, Calif., and ... Dallas."This is a state-of-the-art benzene litigation conference," said ...
... draws from personal experience with American private care ... provincesMIAMI , May 12 ... a Democratic constituent in her Florida district are ... in America in a personal letter to every ...
... that posed by other strains of influenza, CDC says , , ... Tuesday that they,re seeing some complications among pregnant women as ... "Pregnant women are at higher risk of complications of influenza, ... We are also seeing some severe complications in women with ...
... people have many strategies for building bigger muscles and stronger ... brain? , Meditate. , ... who used high-resolution magnetic resonance imaging (MRI) to scan the ... the journal NeuroImage and currently available online (by ...
... May 12 The YWCA USA Annual General Assembly elected new ... National Coordinating Board, during its recent 2009 National Conference in Washington, ... Chair: Debra Stock, Executive Director of YWCA ... Jeanette Castellanos-Butt, Associate Director of YWCA Greater Chicago, Illinois , ...
Cached Medicine News:Health News:Benzene Litigation Conference July 24 2Health News:Florida Congresswoman Sends to Every Member of Senate Canadian-born U.S. Citizen's Prescription for Health Care Reform 2Health News:Swine Flu May Pose Problems for Pregnant Women 2Health News:Swine Flu May Pose Problems for Pregnant Women 3Health News:Swine Flu May Pose Problems for Pregnant Women 4Health News:Swine Flu May Pose Problems for Pregnant Women 5Health News:Swine Flu May Pose Problems for Pregnant Women 6Health News:Swine Flu May Pose Problems for Pregnant Women 7Health News:Swine Flu May Pose Problems for Pregnant Women 8Health News:Swine Flu May Pose Problems for Pregnant Women 9Health News:How to build a bigger brain 2Health News:YWCA USA Elects New National Leadership 2
Weight adjuster flexible back, comfortably places more weight on hips, less weight on shoulders....
All Purpose, General Procedure Apron...
Designed for special procedures, this Wrap-Around apron has .50mm Pb in the front and .25mm Pb in the back. The velcro fasteners are adjustable to provide the most comfortable fit....
Designed to fit the body and priced to fit the budget! The Economy Tie apron has a belt that wraps around the body and ties in the front. Don't let the price fool you.... this apron provides the same...
Medicine Products: